Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial
详细信息 查看全文
- 作者：Mitsuru Adachia ; Caroline Goldfradb ; Loretta Jacquesc ; Yoshie Nishimurad ; yoshie.2.nishimura@gsk.com" class="auth_mail" title="E-mail the corresponding author
- 关键词：Asthma ; Well-controlled asthma ; Inhaled corticosteroid ; Long-acting beta2-agonist ; &lsquo ; Step down&rsquo ; of asthma therapy ; &lsquo ; Step across&rsquo ; of asthma therapy
- 刊名：Respiratory Medicine
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：120
- 期：Complete
- 页码：78-86
- 全文大小：666 K
文摘
- •
Study conducted in Japanese pts with well-controlled asthma on mid dose ICS/LABA.
- •
90.5% of pts maintain control on switch from mid dose ICS/LABA to FF/VI 100/25OD.
- •
Similar efficacy of FF100OD, FP100BD and FP250BD on step down from FF/VI 100/25OD.